Balloon catheter with transient radiopaque marking
Treating a treatment area in the vasculature includes a first catheter adapted for positioning at the treatment area, said first catheter including a first balloon having a transient radiopaque material corresponding to the treatment area. A second catheter adapted for positioning at the treatment area includes a treatment that substantially matches the transient radiopaque material, preferably so that the length and/or position of the treatment corresponds to the length and/or position of the transient radiopaque material. Related kits, assemblies, and methods are also described.
1. A kit for treating a treatment area in the vasculature, comprising:
a first catheter adapted for positioning at the treatment area, said first catheter including a first balloon having a transient radiopaque material corresponding to the treatment area;
and
a second catheter adapted for positioning at the treatment area, said second catheter having a treatment that substantially matches the transient radiopaque material while on the first balloon, so that the length or position of the treatment corresponds to the length or position of the treatment area.
2. The kit of claim 1 , wherein the second catheter includes one or more radiopaque markings for identifying the location of the treatment.
3. The kit of claim 1 , wherein a length of the transient radiopaque material is substantially identical to a length of the treatment.
4. The kit of claim 1 , wherein the second catheter includes a second balloon having a working surface including the treatment.
5. The kit of claim 4 , wherein a position of the transient radiopaque material corresponds to an end of the working surface of the second balloon.
6. The kit of claim 1 , wherein the treatment is selected from the group consisting of a drug, a stent, a stent graft, a cutter, a focused force wire, or any combination thereof.
7. The kit of claim 6 , wherein a length of the treatment substantially matches the length of the transient radiopaque material.
8. The kit of claim 1 , wherein the transient radiopaque material is selected from the group consisting of a radiopaque dye, powder, or gel.
9. The kit of claim 1 , further including a bioresorbable stent including the transient radiopaque material.
10. The kit of claim 1 , wherein the transient radiopaque material comprises a layer of the first balloon.
11. The kit of claim 1 , wherein the transient radiopaque material comprises a strip or band.
12. The kit of claim 1 , wherein the transient radiopaque material is coated over at least a portion of the first balloon, disposed in a porous structure of the first balloon, disposed in wells on the first balloon, provided as a plurality of microdots on the first balloon, present on the first balloon under a membrane, or any combination thereof.
13. The kit of claim 1 , wherein the transient radiopaque material is permanent.
14. The kit of claim 1 , wherein the treatment comprises a therapeutic agent selected from the group consisting of paclitaxel, rapamycin, heparin, or any combination thereof.
15. The kit of claim 14 , wherein the second catheter includes a balloon carrying the therapeutic agent.
16. The kit of claim 1 , wherein the second catheter includes markings that match the location of the transient radiopaque material of the first catheter.
17. A kit for treating a treatment area in the vasculature, comprising:
a first catheter adapted for positioning at the treatment area in the vasculature, said first catheter including a first balloon having a transient radiopaque material having first and second ends corresponding in size to the treatment area;
and
a second catheter adapted for positioning at the treatment area, said second catheter including a treatment having first and second ends corresponding to the first and second ends of the transient radiopaque material on the first balloon.
18. The kit of claim 17 , wherein the second catheter includes one or more radiopaque markings for identifying the location of the treatment.
19. The kit of claim 17 , wherein the treatment is selected from the group consisting of a drug, a stent, a stent graft, a cutter, a focused force wire, or any combination thereof.
20. The kit of claim 19 , wherein a length of the treatment substantially matches the length of the transient radiopaque material.
21. The kit of claim 17 , wherein the second catheter includes a second balloon having a working surface including the treatment.
22. A kit for treating vasculature comprising a balloon catheter and a second catheter
wherein
the balloon catheter has a balloon with a surface having transient radiopaque material in a pattern,
and
the balloon catheter is adapted to mark vasculature in the pattern with transient radiopaque material,
and
wherein the second catheter comprises a treatment corresponding in length to the pattern while on the balloon.
23. A kit for treating vasculature at a treatment area, comprising:
a first catheter adapted for positioning at the treatment area, the first catheter including a first balloon having a transient radiopaque material corresponding to the treatment area;
and
a second catheter adapted for positioning at the treatment area, the second catheter having a treatment wherein the treatment substantially matches the transient radiopaque material in length while on the first balloon.